Compare TG Therapeutics Inc (TGTX) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Under Armour Inc Class A — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Under Armour Inc Class A trades at $7.18 (market cap $3.07B). The key difference: TG Therapeutics Inc is far larger — about 2.7× Under Armour Inc Class A's market cap. Which is the better fit depends on your goals.
| TGTX | UA | |
|---|---|---|
Market Cap | $8.26B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $59.06 | $7.88 |
52-Week Low | $26.39 | $3.96 |
Enterprise Value | $8.50B | $4.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
